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Abstract: The continuing use of high-throughput assays to investigate cellular responses to 
infection  is  providing  a  large  repository  of  information.  Due  to  the  large  number  of 
differentially expressed transcripts, often running into the thousands, the majority of these 
data have not been thoroughly investigated. Advances in techniques for the downstream 
analysis of high-throughput datasets are providing additional methods for the generation of 
additional  hypotheses  for  further  investigation.  The  large  number  of  experimental 
observations, combined with databases that correlate particular genes and proteins with 
canonical pathways, functions and diseases, allows for the bioinformatic exploration of 
functional  networks  that  may  be  implicated  in  replication  or  pathogenesis.  Herein,  we 
provide  an  example  of  how  analysis  of  published  high-throughput  datasets  of  cellular 
responses to hemorrhagic fever virus infection can generate additional functional data. We 
describe enrichment of genes involved in metabolism, post-translational modification and 
cardiac  damage;  potential  roles  for  specific  transcription  factors  and  a  conserved 
involvement of a pathway based around cyclooxygenase-2. We believe that these types of 
analyses can provide virologists with additional hypotheses for continued investigation. 
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Viral hemorrhagic fevers represent an important group of emerging infections: Lassa virus is an 
important public health problem in West Africa and Ebola virus causes sporadic outbreaks associated 
with high mortality. The pathogenesis of hemorrhagic fevers may involve aberrant immune responses 
leading to the dysregulation of cytokines production and vascular leakage. The immune responses to 
hemorrhagic fevers have been extensively studied, with networks based around interferon shown to be 
particularly important. However, the roles of other signaling pathways, both immune and non-immune, 
have not been characterized as thoroughly. In particular, there is relatively little information on the 
effect on pathways involved in basic cellular metabolism and homeostasis. Given the tropism of many 
of these viruses for mononuclear phagocytes and the central role of these cells in mediating immune 
responses, dysregulation of basic function may be an important contributor to pathogenesis.  
The increase in the use of unbiased high-throughput methods, such as transcriptomic microarrays 
and proteomics, has provided a resource of large datasets, which reveal the myriad ways the host-cell 
responds to viral infection. These experiments have, in some ways, been victims of their own success. 
The  large  number  of  differentially  expressed  genes  or  proteins  means  that  not  all  differentially 
expressed genes can be validated. Whole datasets are visualized using techniques such as hierarchical 
clustering, with validation often limited to the genes showing the largest fold change, or those which 
are  hypothesized  to  be involved  in pathogenesis,  such  as immune  response genes. More  recently, 
network analysis has been used to place high-throughput datasets into more of a functional context and 
show expression changes of multiple genes in the same pathway [1]. Gene ontology analysis has been 
used to show the expression of genes in particular functional classes, and promoter enrichment can  
be  used  to  identify  which  transcription  factors  may  be  centrally  involved  in  controlling  gene 
expression [2,3]. 
The understanding of the role of cell signaling pathways may have important implications for the 
development  of  novel  antiviral  therapies.  Inhibiting  cellular  proteins  required  for  replication  or, 
particularly in the case of the hemorrhagic fevers, modulating pathways that lead to immunopathology 
or cellular dysregulation may prove to be an effective therapeutic strategy with a lower risk of the 
evolution  of  resistance  compared  to  inhibiting  viral  proteins.  As  an  example,  a  DNA  aptamer 
containing  the  AP-1  consensus  sequence  has  been  shown  to  protect  guinea  pigs  against  lethal 
arenavirus  challenge  [4].  This  type of  therapeutic  strategy may  also  prove  to  be  effective  against 
several viruses that exploit or manipulate similar cellular pathways.  
We  have  previously  used  network  analysis  to  investigate  cellular  responses  to  Pichindé  virus 
(PICV) infection [5–8]. In this note, we have used network analysis tools to compare cellular responses 
in hemorrhagic fever systems using meta-analysis of published high-throughput datasets. We believe 
that these types of approaches will become increasingly relevant as the number of datasets continues to 
grow, and will play a central role in allowing the development of hypotheses regarding the cellular 
response to viral infection that are focused on under-researched pathways in the field. 
We  created  gene/protein  lists  derived  from  previously  published  high-throughput  datasets: 
microarray  expression  data  from  Ebola  virus  (EBOV)  [9],  lymphocytic  choriomeningitis  virus 
(LCMV) models of Lassa fever [10,11] (from both PBMCs and the liver), Rift Valley fever virus 
(RVFV) [12] and a proteomics dataset from a PICV model of Lassa fever [8]. Where possible, these 
lists were constructed from those genes/proteins that were differentially expressed between attenuated 
and virulent infection.  Viruses 2011, 3                                       
 
 
615 
We began our analysis by uploading the datasets to the Ingenuity Pathway Analysis application [13] 
and looking at an overview of the dataset in the form of enrichment of specific genes associated with 
canonical cell signaling pathways, functions and diseases. As expected, the LCMV datasets showed an 
involvement  in  many  more  pathways  than  the  EBOV,  RVFV  and  PICV  datasets  due  to  the 
significantly  higher  number  of  genes  in  the  datasets.  For  this  reason,  we  chose  not  to  focus  on 
pathways which did not include RVFV, EBOV or PICV. Pathogenic functions identified in RVFV 
predicted  high-significance  of  hepatic  and  renal  disease,  observed  in  clinical  cases  [14].  We  also 
identified potential involvement of EBOV in mediating expression changes of genes associated with 
cardiac  damage,  suggested  to  be  involved  in  EBOV  infection  [15].  Genes  involved  in  regulating  
post-translational modification (PTM) and metabolic pathways including oxidative phosphorylation, 
lysine  degradation,  tyrosine  metabolisms  and  ubiquinone  synthesis  showed  enrichment  following 
arenavirus  infection, in the PICV  and  LCMV liver datasets  in  particular. The relevance for these 
pathways in infection is unclear, however changes in the ability to post-translationally modify proteins 
could have significant effects on many cell signaling pathways; changes in basic metabolism could 
alter homeostasis, reducing the capacity of infected cells to respond to stimuli appropriately. 
A further way to interpret microarray data is to consider the differentially expressed genes as the 
observed  outcome  of  upstream  cell  signaling  events  that  may  be  activated  or  inhibited  by  virus 
infection. By utilizing databases of genome sequence data, we investigated whether any particular 
transcription factor binding sites were associated with the observed transcriptional changes to a greater 
degree than would be expected by chance. We used the PSCAN web server [16] to identify the five 
most significant transcription factors, which may act as ‘master regulators’ in controlling transcription 
in response to infection (Table 1). We selected a region 950 base pairs upstream and 50 base pairs 
downstream  of  the  translational  start  site  for  analysis  using  the  TRANSFAC  database  [17].  Few 
significant transcription factors were identified in the EBOV dataset, with none of the p values being 
significant after Bonferroni correction for multiple hypothesis testing. We speculate that part of the 
reason for this is that the dataset is based on a comparison between infection with wild-type and 
inactivated  virus;  we  hypothesize  that  both  of  these  infections  stimulate  similar  innate  pathogen 
recognition receptors and lead to a number of conserved downstream gene expression changes.  
Table 1. Top five predicted transcription factor binding motifs identified using the PSCAN 
algorithm;  p  values  are  indicated  and  motifs  shown  in  bold  are  those  which  remained 
significant following Bonferroni adjustment for multiple comparisons. 
EBOV  RVFV  LCMV (PBMC)  LCMV (LIVER) 
FAC1 (0.017)  ISRE1 (1.2 × 10
−15)  SP1 (1.2 × 10
−22)  E2F (2.8 × 10
−18) 
NFY (0.018)  IRF7 (2.4 × 10
−10)  E2F (3.9 × 10
−16)  ELK1 (5.6 × 10
−17) 
ATF6 (0.021)  IRF2 (3.6 × 10
−6)  ELK1 (2 × 10
−14)  SP1 (3.7 × 10
−15) 
FOXO4 (0.021)  AP1 (1.3 × 10
−5)  EGR3 (8.7 × 10
−12)  ATF (3.5 × 10
−11) 
RFX1 (0.022)  NF-B (3 × 10
−4)  NRF2 (9.4 × 10
−11)  AP2 (6.3 × 10
−11) 
 
Analysis  of  the  RVFV  dataset  revealed  enrichment  of  promoters  for  the  interferon -inducing 
transcription factors IRF7 and IRF2, consistent with the central role of interferon induction pathways 
in infection and in agreement with the results reported by the  authors in the original study  [12]. Of Viruses 2011, 3                                       
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particular  interest  is  the  group  of  transcription  factors  predicted  to  be  master  regulators  of  the 
responses  to  LCMV  infection  of  PBMCs.  We  also  observed  enrichment  of  binding  sites  for  the 
transcription  factor  SP1,  which  we  had  previously  identified  in  networks  built  following  PICV 
infection, and which showed differential DNA-binding activities between infection with attenuated and 
virulent viruses early during in vitro infection [6]. 
We  next  created  a  network  using  the  Ingenuity  Pathways  Analysis  tool  using  the  implicated 
transcription factors as starting point, we sought to identify the upstream signaling pathways that may 
be involved in regulating their transactivation activities. Using interactions mined from the literature, 
we identified the mitogen-activated protein kinase pathway, p38 in particular, in controlling responses 
to LCMV infection (Figure 1). This is consistent with previously published data that shows activation 
of these signaling molecules and transcription factors in response to PICV infection [18,19]. 
Figure  1.  Signaling  pathways  upstream  of  predicted  transcriptional  regulators  in 
lymphocytic choriomeningitis virus (LCMV) infection of PBMCs. The Ingenuity Pathways 
Analysis application was used to search for proteins known to be involved in controlling 
the activity of transcription factors that bind to motifs identified using PSCAN analysis. 
Shaded proteins were shown to have differential expression by microarray analysis. 
 
 
Combining  bioinformatics-based  pathway  analysis  with  gene  expression  data  allows  for  the 
discovery of cellular pathways and possible interactions that may be overlooked when considering the 
data  in  a  tabular  format.  Following  analysis  of  RVFV  expression  data  in  the  form  of  predicted 
significance  of  canonical  pathways  and  functions,  we  identified  a  network  based  around 
cyclooxygenase-2 (COX-2). Overlaying expression data from the microarray revealed downregulation 
of COX-2 expression, despite upregulation of IL-6 and STAT1, both of which have been shown to 
induce  COX-2  expression  (Figure  2).  Interestingly,  COX-2  has  also  been  implicated  in  other 
hemorrhagic fever infections and models, showing downregulation in the LCMV macaque model [11], 
upregulation in both EBOV and Dengue infection [20,21]. The conserved identification of changes in 
COX-2 expression and activation of its regulatory networks suggest that this might be a potential target 
for further investigation. Viruses 2011, 3                                       
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Figure 2. Regulation of a signaling network based around cyclooxygenase-2 (PTGS2). The 
Ingenuity Pathways Analysis application was used to construct a network on the basis of 
known protein and gene interactions, expression data from the Rift Valley fever microarray 
study is overlayed: red indicates upregulation, green indicates downregulation. 
 
 
We have used web-based bioinformatics applications to investigate cellular responses to infection 
with hemorrhagic fever viruses. As additional datasets become available, our ability to investigate 
common and specific responses to viral infection will continue to grow, particularly as additional 
bioinformatics analysis tools and databases are developed. In particular, as the number of datasets 
describing models of varying pathogenesis increases, we will be better placed to perform comparative 
analyses  to  define  the  cellular  responses  associated  with  attenuation,  facilitating  rational  vaccine 
design [22]. In this report, we have shown how currently available bioinformatics tools can be used to 
leverage the additional data from high-throughput studies to generate additional hypotheses for further 
testing. These types of analyses may provide additional clues toward understanding how hemorrhagic 
fever virus infection perturbs cellular functions and playing a role in uniting virus-host interactions at 
the molecular and cellular level with the mechanisms which underlie clinical pathology. 
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